Cardiac Toxicity Completed Phase 3 Trials for Leucovorin (DB00650)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01230983Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's LymphomaSupportive Care